Pathstone Family Office’s Prestige Consumer Healthcare PBH Stock Holding History
Bought
Maintained
Sold
Other funds holding PBH
WHG
Pathstone Family Office's PBH Position: Q1 2023 in Review
Pathstone Family Office sold out of Prestige Consumer Healthcare (PBH) in Q1 2023, closing a stake of 5,169 shares — an estimated $325K sold.
Pathstone Family Office first reported a position in PBH in Q2 2014 and held it in 9 quarters. The position peaked at $325K in Q4 2022. 283 funds tracked by Wall St. Rank hold PBH as of Q1 2023.
- Pathstone Family Office reported no remaining Prestige Consumer Healthcare position as of Q1 2023 after selling out during the quarter.
- Pathstone Family Office sold 5,169 Prestige Consumer Healthcare shares in Q1 2023, an estimated $325K.
- Pathstone Family Office first reported a position in Prestige Consumer Healthcare in Q2 2014 and held it in 9 quarters.
- Pathstone Family Office's Prestige Consumer Healthcare position peaked at $325K in Q4 2022.
- 283 funds tracked by Wall St. Rank held Prestige Consumer Healthcare as of Q1 2023.
Based on Pathstone Family Office's 13F filing for Q1 2023, filed 15 May 2023.